ArticleBrain research2011

Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Catherine H Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.